Crescent Biopharma, Inc. Cash Flow Quality Index
Crescent Biopharma, Inc. cash flow quality index. Crescent Biopharma, Inc. (CBIO) has a Cash Flow Quality Index of -0.59x as of June 2015. Operating cash flow of $-6.14 Million is below net income of $10.39 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Crescent Biopharma, Inc. to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Crescent Biopharma, Inc. (2012–2012)
Cash flow quality index of Crescent Biopharma, Inc. from 2012 to 2012. Historical Cash Flow Quality Index for Crescent Biopharma, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CBIO operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Crescent Biopharma, Inc. Cash Flow Quality Index by Year (2012–2012)
Crescent Biopharma, Inc. cash flow quality index by year from 2012 to 2012. Year-by-year earnings quality comparison for Crescent Biopharma, Inc.. For the full cash flow conversion analysis, see Crescent Biopharma, Inc. operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2012 | -2.86x | $-10.47 Million | $3.66 Million | — |